| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 19 |
| 1 | NIVOLUMAB | 13 |
| 2 | CELECOXIB | 7 |
| 3 | CITALOPRAM | 7 |
| 4 | CITALOPRAM HYDROBROMIDE | 7 |
| 5 | CYCLOBENZAPRINE | 7 |
| 6 | GABAPENTIN | 7 |
| 7 | SIMVASTATIN | 7 |
| 8 | ATEZOLIZUMAB | 6 |
| 9 | LISINOPRIL AND HYDROCHLOROTHIAZIDE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MITOTANE | 1 | 0.0005 |
| 1 | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | 4 | 0.0005 |
| 2 | CEMIPLIMAB-RWLC | 1 | 0.0005 |
| 3 | RAMUCIRUMAB | 2 | 0.0003 |
| 4 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 2 | 0.0002 |
| 5 | METHYLDOPA | 1 | 0.0002 |
| 6 | EFAVIRENZ | 2 | 0.0002 |
| 7 | PEMBROLIZUMAB | 19 | 0.0002 |
| 8 | ATEZOLIZUMAB | 6 | 0.0002 |
| 9 | CYCLOBENZAPRINE | 7 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 13 | 0.0001 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0001 |
| 3 | Serotonin Reuptake Inhibitor [EPC] | 7 | 0.0001 |
| 4 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 4 | 0.0001 |
| 5 | CTLA-4-directed Blocking Antibody [EPC] | 2 | 0.0000 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Pyridone [EPC] | 1 | 0.0000 |
| 8 | Purine Antimetabolite [EPC] | 2 | 0.0000 |
| 9 | Thiazide Diuretic [EPC] | 4 | 0.0000 |